Undervalued Small Caps With Insider Action In Hong Kong October 2024

In This Article:

As Hong Kong's Hang Seng Index experiences a significant rally, buoyed by China's sweeping stimulus measures aimed at revitalizing its economy, investors are keenly watching the small-cap sector for potential opportunities. In this dynamic environment, identifying stocks with strong fundamentals and insider action can offer insights into companies that may be well-positioned to capitalize on the current economic momentum.

Top 5 Undervalued Small Caps With Insider Buying In Hong Kong

Name

PE

PS

Discount to Fair Value

Value Rating

Edianyun

NA

0.8x

27.27%

★★★★★☆

Vesync

7.7x

1.1x

-10.13%

★★★★☆☆

Ferretti

10.7x

0.7x

48.07%

★★★★☆☆

Beijing Chunlizhengda Medical Instruments

14.7x

3.2x

46.97%

★★★★☆☆

Hang Lung Group

7.6x

1.3x

49.81%

★★★★☆☆

Gemdale Properties and Investment

NA

0.3x

21.47%

★★★★☆☆

China Lesso Group Holdings

6.9x

0.5x

-622.73%

★★★☆☆☆

Skyworth Group

6.4x

0.1x

-347.51%

★★★☆☆☆

Emperor International Holdings

NA

0.9x

21.61%

★★★☆☆☆

Click here to see the full list of 9 stocks from our Undervalued SEHK Small Caps With Insider Buying screener.

Let's explore several standout options from the results in the screener.

Hang Lung Group

Simply Wall St Value Rating: ★★★★☆☆

Overview: Hang Lung Group is a real estate company primarily engaged in property leasing and sales in Hong Kong and Mainland China, with a market capitalization of HK$28.75 billion.

Operations: The group's revenue is primarily driven by property leasing in Mainland China and Hong Kong, with a smaller contribution from property sales in Hong Kong. The gross profit margin has shown variability, reaching 71.96% as of December 2023, before declining to 63.42% by June 2024. Operating expenses have been consistently managed around HK$680 million to HK$693 million over recent periods, impacting the net income outcomes alongside significant non-operating expenses.

PE: 7.6x

Hang Lung Group, a smaller player in Hong Kong's market, has caught attention due to insider confidence shown by Wenbwo Chan's purchase of 200,000 shares for HK$1.93 million in July 2024. Despite a drop in net income to HK$888 million for the first half of 2024 from HK$1.68 billion last year and shrinking profit margins, the company's sales rose to HK$6.38 billion from HK$5.53 billion year-over-year. The interim dividend was maintained at HKD 0.21 per share, reflecting stable shareholder returns amidst challenging earnings conditions and reliance on external borrowing as its primary funding source.